IART

Integra LifeSciences Holdings

9.37

USD

IART Earnings Reports

Positive Surprise Ratio

IART beat 24 of 41 last estimates.

59%

Next Report

Date of Next Report

May 04, 2026

Estimate for Q1 26 (Revenue/ EPS)

$389.51M

$0.41

Implied change from Q4 25 (Revenue/ EPS)

-10.44%

-50.60%

Implied change from Q1 25 (Revenue/ EPS)

+1.79%

Integra LifeSciences Holdings earnings per share and revenue

On Feb 26, 2026, IART reported earnings of 0.83 USD per share (EPS) for Q4 25, beating the estimate of 0.81 USD, resulting in a 1.68% surprise. Revenue reached 434.93 million, compared to an expected 438.21 million, with a -0.75% difference. The market reacted with a -2.24% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 10 analysts forecast an EPS of 0.41 USD, with revenue projected to reach 389.51 million USD, implying an decrease of -50.60% EPS, and decrease of -10.44% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

ClearPoint Neuro, Inc. Common Stock

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.20

Actual

-$0.26

Surprise

-27.45%

EDAP TMS SA

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.13

Actual

-$0.21

Surprise

-65.56%

Hyperfine, Inc. Class A Common Stock

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.05

Surprise

+38.73%

Neuronetics, Inc. Common Stock

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.10

Actual

-$0.10

Surprise

+8.09%

Rapid Micro Biosystems, Inc. Class A Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

-$0.22

Actual

-$0.28

Surprise

-23.35%

InspireMD, Inc.

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.14

Surprise

+29.01%

DarioHealth Corp. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$3.30

Actual

-$3.43

Surprise

-3.71%

Spectral AI, Inc. Class A Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.12

Actual

-$0.11

Surprise

+14.86%

SiNtx Technologies, Inc. Common Stock

Report Date

Mar 20, 2026 For Q4 25

Estimate

-$0.56

Actual

-$0.56

Surprise

-1.60%

Tenon Medical, Inc. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.36

Actual

-$0.38

Surprise

-3.49%

FAQ

What were Integra LifeSciences Holdings's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Integra LifeSciences Holdings reported EPS of $0.83, beating estimates by 1.68%, and revenue of $434.93M, -0.75% below expectations.

How did the market react to Integra LifeSciences Holdings's Q4 2025 earnings?

The stock price moved down -2.24%, changed from $11.59 before the earnings release to $11.33 the day after.

When is Integra LifeSciences Holdings expected to report next?

The next earning report is scheduled for May 04, 2026.

What are the forecasts for Integra LifeSciences Holdings's next earnings report?

Based on 10 analysts, Integra LifeSciences Holdings is expected to report EPS of $0.41 and revenue of $389.51M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.